Maher Bill - Insider Non-Derivative Transactions at abrdn Life Sciences Investors (HQL) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 23, 2024, Maher Bill's relationship to abrdn Life Sciences Investors (HQL) is Director, and currently has 1,715.21 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other HQL insiders.

Data Source: SEC.
Maher Bill - Insider Non-Derivative Transactions of HQL Common Stock
Maher Bill - Insider Non-Derivative Transactions at HQL
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 24, 2024 P -- (Common Stock) 650 15.37 1715.21
Dec 29, 2023 P -- (Common Stock) 1000 13.57 1000